<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01078324</url>
  </required_header>
  <id_info>
    <org_study_id>03-11-115-12</org_study_id>
    <secondary_id>K24DK002650</secondary_id>
    <nct_id>NCT01078324</nct_id>
  </id_info>
  <brief_title>Study of Ischemic Colitis Compared to Other Diagnoses in Patients With Lower Gastrointestinal Bleeding</brief_title>
  <official_title>Ischemic Colitis Is a Common Cause of Severe Hematochezia and Patient Outcomes Are Worse Than With Other Colonic Diagnoses</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University of California, Los Angeles</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)</agency>
      <agency_class>NIH</agency_class>
    </collaborator>
  </sponsors>
  <source>University of California, Los Angeles</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this study is to study the demographic,laboratory,endoscopic, and outcomes of
      ischemic colitis patient presented with severe lower gastrointestinal bleeding compared to
      other diagnoses.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Secondary purpose of this study is to assess the risk factors for predicting diverticulosis
      versus ischemic colitis.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>December 1997</start_date>
  <completion_date type="Actual">December 2009</completion_date>
  <primary_completion_date type="Actual">December 2009</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>The clinical course and outcomes of the ischemic colitis group compared to other colonic diagnoses group</measure>
    <time_frame>12 year period</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Risk factors and prediction of ischemic colitis versus diverticulosis as the cause of severe hematochezia</measure>
    <time_frame>12 year period</time_frame>
  </secondary_outcome>
  <number_of_groups>1</number_of_groups>
  <enrollment type="Actual">550</enrollment>
  <condition>Colitis, Ischemic</condition>
  <arm_group>
    <arm_group_label>Ischemic colitis</arm_group_label>
    <description>Ischemic colitis, Diverticulosis</description>
  </arm_group>
  <eligibility>
    <study_pop>
      <textblock>
        Patients who were admitted into the hospital
      </textblock>
    </study_pop>
    <sampling_method>Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  bright red blood clots or burgundy colored stool documented by a health care worker

          -  clinical or laboratory evidence of significant blood loss, manifested by any one of
             the following: (a) more than three bloody bowel movements in eight hours (b) a
             decrease of two grams of hemoglobin (Hgb) from baseline, or (c) transfusion of more
             than three units of red blood cell (URBC).

        Exclusion Criteria:

          -  age less than 18 year

          -  history of inflammatory bowel disease

          -  hypotension or shock refractory to resuscitation

          -  severe coagulopathy refractory to resuscitation (platelet count &lt; 30,000; prothrombin
             time [PT]- more than 2 times normal; partial thromboplastin time [PTT]- more than 2
             times normal)

          -  acquired immune deficiency syndrome or neutropenia

          -  the inability to provide informed consent

          -  documentation of anal disorders as a cause of bleeding such as internal hemorrhoids,
             anal fissures, polyps or cancer of the anal canal, and fistulae
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Dennis M Jensen, M.D.</last_name>
    <role>Principal Investigator</role>
    <affiliation>University of California, Los Angeles</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>The Veterans Affairs Greater Los Angeles Medical Center</name>
      <address>
        <city>Los Angeles</city>
        <state>California</state>
        <zip>90073</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <reference>
    <citation>Jensen DM, Machicado GA. Diagnosis and treatment of severe hematochezia. The role of urgent colonoscopy after purge. Gastroenterology. 1988 Dec;95(6):1569-74.</citation>
    <PMID>3263294</PMID>
  </reference>
  <reference>
    <citation>Jensen DM, Machicado GA. Colonoscopy for diagnosis and treatment of severe lower gastrointestinal bleeding. Routine outcomes and cost analysis. Gastrointest Endosc Clin N Am. 1997 Jul;7(3):477-98. Review.</citation>
    <PMID>9177148</PMID>
  </reference>
  <reference>
    <citation>Jensen DM, Machicado GA, Jutabha R, Kovacs TO. Urgent colonoscopy for the diagnosis and treatment of severe diverticular hemorrhage. N Engl J Med. 2000 Jan 13;342(2):78-82.</citation>
    <PMID>10631275</PMID>
  </reference>
  <verification_date>August 2016</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>March 1, 2010</study_first_submitted>
  <study_first_submitted_qc>March 1, 2010</study_first_submitted_qc>
  <study_first_posted type="Estimate">March 2, 2010</study_first_posted>
  <last_update_submitted>August 17, 2016</last_update_submitted>
  <last_update_submitted_qc>August 17, 2016</last_update_submitted_qc>
  <last_update_posted type="Estimate">August 19, 2016</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Ischemia</mesh_term>
    <mesh_term>Colitis</mesh_term>
    <mesh_term>Colitis, Ischemic</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

